• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Resources
    • Webinars
    • Events
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Resources
    • Webinars
    • Events
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

AbbVie

Hospitals

Bristol Myers Squibb latest to roll out 340B restrictions

Bristol Myers Squibb became the 12th drugmaker, and second in the past month, to announce a policy for 340B contract pharmacy restrictions.
Robert King Jan 19, 2022 9:30am

AbbVie latest to impose 340B sales restrictions

Jan 5, 2022 9:30am

House Dems: 14 drugmakers spent $577B on buybacks, dividends

Jul 9, 2021 7:05am

Healthcare stocks rise following midterm election—roundup

Nov 9, 2018 12:05am

Questions about disclosures, studies bring down 2 researchers

Sep 20, 2018 1:05pm

Cigna expands its collaboration with Omada Health—roundup

Sep 19, 2018 8:39am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy